Description
MRTX113 is a potent and selective inhibitor of KRASG12D protein.
Product Unit Size | Cost | Quantity | Stock |
---|
MRTX113 is a potent and selective inhibitor of KRASG12D protein.
Cas No. | 2621928-55-8 |
---|---|
Purity | ≥98% |
Formula | C33H31F3N6O2 |
Formula Wt. | 600.65 |
IUPAC Name | 4-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoronaphthalen-2-ol |
Synonym | NSC-836407 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Issahaku A, Mukelabai N, Agoni C, et al. Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy. Sci Rep. 2022 Oct 22;12(1):17796. PMID: 36273239
Hallin J, Bowcut V, Calinisan A, et al. Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor. Nat Med. 2022 Oct;28(10):2171-2182. PMID: 36216931
Wang X, Allen S, Blake J, et al. Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor. J Med Chem. 2022 Feb 24;65(4):3123-3133. PMID: 34889605
Synthetic steroid hormone used in HRT; SERM, PR...
β1-adrenergic agonist, β2- and α1-adrenergic...
Peptide, protease substrate.
Snake venom found in Bothrops neuwiedi diporus;...
FGFR inhibitor.
Peptide antigen fragment
Paclitaxel derivative
Calcitonin-family peptide, involved in vasodila...
Carcinoembryonic antigen epitope.
β-lactam carbapenem; penicillin binding protei...
Synthesis impurity
β2-adrenergic agonist.
TLR7 agonist
Nucleoside (deoxycytidine) analog; ribonucleoti...
M3 mAChR antagonist.
Hydrophobic β-lactam; penicillin binding prote...
Nucleoside (adenosine) analog; DNA chain termin...
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...
Purine nucleoside analog; DNA chain terminator....